The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

We performed a multicenter survey using a semistructured interview in 1,072 consecutive patients with Parkinson's disease (PD) enrolled during 12 months in 55 Italian centers to assess the prevalence of nonmotor symptoms (NMSs), their association with cognitive impairment, and the impact on pat...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 24; no. 11; pp. 1641 - 1649
Main Authors Barone, Paolo, Antonini, Angelo, Colosimo, Carlo, Marconi, Roberto, Morgante, Letterio, Avarello, Tania P., Bottacchi, Eugenio, Cannas, Antonino, Ceravolo, Gabriella, Ceravolo, Roberto, Cicarelli, Giulio, Gaglio, Roberto M., Giglia, Rosa M., Iemolo, Francesco, Manfredi, Michela, Meco, Giuseppe, Nicoletti, Alessandra, Pederzoli, Massimo, Petrone, Alfredo, Pisani, Antonio, Pontieri, Francesco E., Quatrale, Rocco, Ramat, Silvia, Scala, Rosanna, Volpe, Giuseppe, Zappulla, Salvatore, Bentivoglio, Anna Rita, Stocchi, Fabrizio, Trianni, Giorgio, Dotto, Paolo Del
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.08.2009
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We performed a multicenter survey using a semistructured interview in 1,072 consecutive patients with Parkinson's disease (PD) enrolled during 12 months in 55 Italian centers to assess the prevalence of nonmotor symptoms (NMSs), their association with cognitive impairment, and the impact on patients' quality of life (QoL). We found that 98.6% of patients with PD reported the presence of NMSs. The most common were as follows: fatigue (58%), anxiety (56%), leg pain (38%), insomnia (37%), urgency and nocturia (35%), drooling of saliva and difficulties in maintaining concentration (31%). The mean number of NMS per patient was 7.8 (range, 0–32). NMS in the psychiatric domain were the most frequent (67%). Frequency of NMS increased along with the disease duration and severity. Patients with cognitive impairment reported more frequently apathy, attention/memory deficit, and psychiatric symptoms. Apathy was the symptom associated with worse PDQ‐39 score but also presence of fatigue, attention/memory, and psychiatric symptoms had a negative impact on QoL. These findings further support a key role for NMS in the clinical frame of PD and the need to address them specifically in clinical trials using dedicated scales. © 2009 Movement Disorder Society
Bibliography:Members of the "PRIAMO Study Group" are listed as an Appendix. Potential conflict of interest: Angelo Antonini, Paolo Barone, Carlo Colosimo, Roberto Marconi, and Letterio Morgante have received consultancy fees from Boehringer-Ingelheim, Italy.
istex:C2707E76FBB6EAF18B68003488BBC42442387A40
ark:/67375/WNG-MRZPBBNX-V
ArticleID:MDS22643
Members of the “PRIAMO Study Group” are listed as an
Potential conflict of interest: Angelo Antonini, Paolo Barone, Carlo Colosimo, Roberto Marconi, and Letterio Morgante have received consultancy fees from Boehringer‐Ingelheim, Italy.
Appendix
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.22643